Abbott Laboratories

Yahoo Finance • 4 hours ago

Blood Collection Market Forecast and Competitive Strategy Report 2025-2033: Abbott, BD, Roche and Siemens Healthineers Lead as Global Players Drive Innovation and Integrated Solutions

Company Logo The blood collection market offers growth opportunities driven by increased demand for automated systems, expanding diagnostic and treatment applications, and personalized medicine. Key regions include North America, Europe,... Full story

Yahoo Finance • 3 days ago

Don't Overlook These 2 Dividend Kings in Today's Volatile Market

Key Points Coca-Cola and Abbott Laboratories have increased their dividends for a combined 116 consecutive years. Coca-Cola has a resilient business due to its diversified portfolio and a constant stream of new launches. Abbott Laboratori... Full story

Yahoo Finance • 3 days ago

Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 81% of the company

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to their trading actions 49% of the business is held by the top 25 shareholders Insiders have sold recently AI is about to chan... Full story

Yahoo Finance • 3 days ago

Dividend Paying Stocks With Stability: AbbVie’s (ABBV) Consistent Record

AbbVie Inc. (NYSE:ABBV) is included among the 12 Best Dividend Paying Stocks to Buy Now.Dividend Paying Stocks With Stability: AbbVie’s (ABBV) Consistent Record AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company that was spun off from Ab... Full story

Yahoo Finance • 4 days ago

Pivot Bio CEO to Spotlight the Commercial Opportunity of Sustainability and Innovation in Agriculture at Climate Week NYC

NEW YORK, Sept. 19, 2025 /PRNewswire/ -- Pivot Bio, one of the world's most innovative agtech companies, will take center stage during Climate Week in New York City (Sept. 22–24). CEO Chris Abbott will join global business and sustainabili... Full story

Yahoo Finance • 5 days ago

Smart Medical Devices Market Size to Reach $180.4 Billion by 2033 - Strategic Growth Opportunities in Chronic Disease Management, Digital Health, and Connected Care

AUSTIN, Texas and TOKYO, Sept. 19, 2025 /PRNewswire/ -- The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the l... Full story

Yahoo Finance • 5 days ago

Abbott Declares 407th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., Sept. 19, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share. This marks the 407th consecutive quarterly dividend to be paid by Abbott sinc... Full story

Yahoo Finance • 6 days ago

AI in Remote Patient Monitoring Market Projected to Reach US$ 10.35 Billion by 2033, Expanding at 6.7% CAGR, According to DataM Intelligence

AUSTIN, Texas and TOKYO, Sept. 18, 2025 /PRNewswire/ -- According to DataM Intelligence, the global AI in remote patient monitoring market reached US$ 5.45 billion in 2023, with a rise to US$ 5.78 billion in 2024, and is expected to reach... Full story

Yahoo Finance • 6 days ago

FCIcoin Shares Vision for the Future of Blockchain

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- FCIcoin, a leading innovator in blockchain-based financial infrastructure, today shared an expanded strategic vision for the future of blockchain, emphasizing its commitment to building secure... Full story

Yahoo Finance • 9 days ago

US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic

Company Logo The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from US$ 2 billion in 2024, reflecting a CAGR of 7.11% from 2025 to 2033. This growth is driven by increasi... Full story

Yahoo Finance • 9 days ago

Peter Lynch Detailed Fundamental Analysis - ABT

Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for s... Full story

Yahoo Finance • 11 days ago

Is Now The Time To Put Abbott Laboratories (NYSE:ABT) On Your Watchlist?

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story even if these companies are loss-making. Sometimes these stories can cloud the minds of investors, leading them to invest... Full story

Yahoo Finance • 12 days ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Opendoor Technologies Inc. 147,272,395 10.38 9.61 9.965 -0.555 Next Tech... Full story

Yahoo Finance • 14 days ago

ABT Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for s... Full story

Yahoo Finance • 14 days ago

White House mulls restrictions on medicines invented in China: NYT

[capsules showcases the flag of United State of America and China] Love Employee/iStock via Getty Images White House officials are working on a draft executive order, which, if enacted, could impose harsh restrictions on experimental trea... Full story

Yahoo Finance • 14 days ago

MedtechWOMEN Announces Virginia L. Giddings as Winner of the 2025 Ferolyn Powell Award

Celebrating outstanding leadership, innovation, and mentorship in medtech MENLO PARK, Calif., September 10, 2025--(BUSINESS WIRE)--MedtechWOMEN today announced that Virginia Giddings, Ph.D., vice president of Exploration at Edwards Lifesc... Full story

Yahoo Finance • 14 days ago

Medtronic plc (MDT) Announces FDA Approval for SmartGuard Algorithm as Automated Glycemic Controller

Medtronic plc (NYSE:MDT) is one of the 14 Tech Stocks to Sell Now According to Ken Fisher.Medtronic plc (MDT) Announces FDA Approval for SmartGuard Algorithm as Automated Glycemic Controller On September 2, 2025, Medtronic plc (NYSE:MDT)... Full story

Yahoo Finance • 15 days ago

Three key points from the new MAHA report

[President Trump Attends MAHA Commission Event At White House] Chip Somodevilla/Getty Images News The Trump administration’s Make America Healthy Again Commission released its second report on Tuesday, noting that dietary factors, synthet... Full story

Yahoo Finance • 15 days ago

5 Dividend Aristocrats Where Analysts See Capital Gains

To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to att... Full story

Yahoo Finance • 17 days ago

Buy Abbott Laboratories (ABT) If You’re Worried About COVID, Says Jim Cramer

We recently published 10 Stocks Jim Cramer Discussed As He Warned About Big Risk To Big Tech. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT) is one of the largest pharmace... Full story